PCVX position history
The shares of Vaxcyte (PCVX) that MAVERICK CAPITAL LTD reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q1: 355,131 shares, $24M, 0.46% of portfolio, New
- 2024 Q2: 687,908 shares, $52M, 0.99% of portfolio, Add +93.7%
- 2024 Q3: 976,249 shares, $112M, 2.2% of portfolio, Add +41.9%
- 2024 Q4: 1,201,898 shares, $98M, 1.8% of portfolio, Add +23.1%
- 2025 Q1: 1,208,093 shares, $46M, 0.81% of portfolio, Add +0.5%
- 2025 Q2: 1,310,605 shares, $43M, 0.64% of portfolio, Add +8.5%
- 2025 Q3: 1,289,567 shares, $46M, 0.62% of portfolio, Reduce −1.6%
- 2025 Q4: 1,354,237 shares, $62M, 0.67% of portfolio, Add +5.0%
- 2026 Q1: 1,377,738 shares, $80M, 0.92% of portfolio, Add +1.7%
- 2026 Q2: 1,613,242 shares, $94M, 0.83% of portfolio, Add +17.1%
- 2026 Q3: 1,360,031 shares, $77M, 0.60% of portfolio, Reduce −15.7%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|